References
- Hedegaard H, Warner M, Minino AM. Drug Overdose Deaths in the United States, 1999-2015. NCHS Data Brief. 2017;273:1–8.
- Wheeler E, Jones TS, Gilbert MK, Davidson PJ. Opioid overdose prevention programs providing Naloxone to Laypersons - United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64: 631–635.
- Macrae J, Hyde PS, Slavitt A. HHS launches multi-pronged effort to combat opioid abuse. 2015. Accessed August 22, 2017. (Archived by WebCite® at http://www.webcitation.org/6tPFLPl0X).
- Dwyer K, Walley AY, Langlois BK, et al. Opioid education and nasal naloxone rescue kits in the emergency department. Westjem. 2015;16:381–384.
- Kestler A, Buxton J, Meckling G, et al. Factors associated with participation in an emergency department-based take-home Naloxone program for At-Risk opioid users. Ann Emerg Med. 2017;69:340–346.
- Pade P, Fehling P, Collins S, Martin L. Opioid overdose prevention in a residential care setting: Naloxone education and distribution. Subst Abus. 2017;38:113–117.
- Yokell MA, Green TC, Bowman S, McKenzie M, Rich JD. Opioid overdose prevention and naloxone distribution in Rhode Island. Med Health R. I 2011;94:240–242.
- Devries J, Rafie S, Polston G. Implementing an overdose education and naloxone distribution program in a health system. J Am Pharm Assoc (2003). 2017;57:S154–S160.
- Oliva EM, Christopher ML, Wells D, et al. Opioid overdose education and naloxone distribution: Development of the Veterans Health Administration's national program. J Am Pharm Assoc (2003). 2017;57:S168–S179. e164.
- Duvivier H, Gustafson S, Greutman M, et al. Indian Health Service pharmacists engaged in opioid safety initiatives and expanding access to naloxone. J Am Pharm Assoc (2003). 2017;57:S135–S140.
- Morton KJ, Harrand B, Floyd CC, et al. Pharmacy-based statewide naloxone distribution: A novel "top-down, bottom-up" approach. J Am Pharm Assoc (2003). 2017;57:S99–S106. e105.
- Coffin PO, Behar E, Rowe C, et al. Nonrandomized intervention study of Naloxone coprescription for primary care patients receiving long-term opioid therapy for pain. Ann Intern Med. 2016;165:245–252.
- Binswanger IA, Koester S, Mueller SR, et al. Overdose education and Naloxone for patients prescribed opioids in primary care: A qualitative Study of Primary Care Staff. J Gen Intern Med. 2015;30:1837–1844.
- Drainoni ML, Koppelman EA, Feldman JA, et al. Why is it so hard to implement change? A qualitative examination of barriers and facilitators to distribution of naloxone for overdose prevention in a safety net environment. BMC Res Notes. 2016;9:465.
- Lacroix L, Thurgur L, Orkin AM, Perry JJ, Stiell IG. Emergency physicians' attitudes and perceived barriers to the implementation of take-home naloxone programs in Canadian emergency departments. CJEM. 2018;20:46–52.
- Bailey AM, Wermeling DP. Naloxone for opioid overdose prevention: pharmacists' role in community-based practice settings. Ann Pharmacother. 2014;48:601–606.
- Behar E, Rowe C, Santos GM, et al. Acceptability of Naloxone Co-Prescription among primary care providers treating patients on long-term opioid therapy for pain. J Gen Intern Med. 2017;32:291–295.
- Siegler A, Huxley-Reicher Z, Maldjian L, et al. Naloxone use among overdose prevention trainees in New York City: A longitudinal cohort study. Drug Alcohol Depend. 2017;179:124–130.